Literature DB >> 32671716

Predictors of conduction recovery after permanent pacemaker implantation following transcatheter aortic valve replacement.

Derek Q Phan1, Jesse Goitia1, Ming-Sum Lee1, Nigel Gupta2, Vicken Aharonian3, Prakash Mansukhani3, Naing Moore3, Somjot S Brar3, Ray Zadegan4.   

Abstract

PURPOSE: Conduction disturbances after transcatheter aortic valve replacement (TAVR) requiring pacemaker (PPM) implantation are a known complication and may be reversible. Therefore, we sought to evaluate the incidence and predictors for atrioventricular (AV) conduction recovery after TAVR.
METHODS: A single-center, retrospective study of patients undergoing PPM implantation for conduction disorders after TAVR between June 2011 and March 2019. Conduction recovery was defined as ≤ 1% ventricular pacing (VP) on follow-up PPM interrogation.
RESULTS: A total of 110 patients (mean age 83.6 ± 6.6 years, 46.8% female) were included. At a median follow-up of 438 days (interquartile range [IQR] 111-760 days), 35 patients (32%) had conduction recovery, with 50% of these occurring within the first 6 months. On multivariate analysis, predictors of conduction recovery include female sex (hazard ratio [HR] 2.5, 95% confidence interval [CI] 1.01-6.4, p = 0.048), non-VP/non-complete heart block rhythm immediately post-TAVR (HR 5.2, 95% CI 1.5-18.1, p = 0.011), normal sinus rhythm 7 days post-TAVR (HR 3.9, 95% CI 1.7-9.2, p = 0.002), and smaller valve size (mm) (HR 0.81, 95% CI 0.7-0.996, p = 0.045). Significant narrowing of the QRS and resolution of new-onset left bundle branch block within 1 month post-TAVR occurred in those with conduction recovery on PPM interrogation.
CONCLUSIONS: One-third of patients receiving new PPM implantation have conduction recovery after TAVR, with 50% occurring within the first 6 months. Patient gender, valve size, and rhythm on serial ECGs after TAVR can help identify patients that may recover AV conduction. A conservative approach rather than immediate PPM implantation may be considered in these patients.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Conduction disease; Electrocardiogram; Permanent pacemaker; Transcatheter aortic valve replacement

Year:  2020        PMID: 32671716     DOI: 10.1007/s10840-020-00813-y

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  24 in total

Review 1.  Impact of New-Onset Left Bundle Branch Block and Periprocedural Permanent Pacemaker Implantation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.

Authors:  Ander Regueiro; Omar Abdul-Jawad Altisent; María Del Trigo; Francisco Campelo-Parada; Rishi Puri; Marina Urena; François Philippon; Josep Rodés-Cabau
Journal:  Circ Cardiovasc Interv       Date:  2016-05       Impact factor: 6.546

2.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

3.  Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry.

Authors:  Opeyemi O Fadahunsi; Abiola Olowoyeye; Anene Ukaigwe; Zhuokai Li; Amit N Vora; Sreekanth Vemulapalli; Eric Elgin; Anthony Donato
Journal:  JACC Cardiovasc Interv       Date:  2016-11-14       Impact factor: 11.195

4.  Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies.

Authors:  Prateek J Khatri; John G Webb; Josep Rodés-Cabau; Stephen E Fremes; Marc Ruel; Kelly Lau; Helen Guo; Harindra C Wijeysundera; Dennis T Ko
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

5.  Incidence and Predictors of Pacemaker Implantation in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Abhishek Maan; Marwan M Refaat; Edwin Kevin Heist; Jonathan Passeri; Ignacio Inglessis; Leon Ptaszek; Gus Vlahakes; Jeremy N Ruskin; Igor Palacios; Thoralf Sundt; Moussa Mansour
Journal:  Pacing Clin Electrophysiol       Date:  2015-05-28       Impact factor: 1.976

6.  Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.

Authors:  Tamim M Nazif; José M Dizon; Rebecca T Hahn; Ke Xu; Vasilis Babaliaros; Pamela S Douglas; Mikhael F El-Chami; Howard C Herrmann; Michael Mack; Raj R Makkar; D Craig Miller; Augusto Pichard; E Murat Tuzcu; Wilson Y Szeto; John G Webb; Jeffrey W Moses; Craig R Smith; Mathew R Williams; Martin B Leon; Susheel K Kodali
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

7.  Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

Authors:  Jeffrey J Popma; David H Adams; Michael J Reardon; Steven J Yakubov; Neal S Kleiman; David Heimansohn; James Hermiller; G Chad Hughes; J Kevin Harrison; Joseph Coselli; Jose Diez; Ali Kafi; Theodore Schreiber; Thomas G Gleason; John Conte; Maurice Buchbinder; G Michael Deeb; Blasé Carabello; Patrick W Serruys; Sharla Chenoweth; Jae K Oh
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

8.  2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

Authors:  Frederick L Grover; Sreekanth Vemulapalli; John D Carroll; Fred H Edwards; Michael J Mack; Vinod H Thourani; Ralph G Brindis; David M Shahian; Carlos E Ruiz; Jeffrey P Jacobs; George Hanzel; Joseph E Bavaria; E Murat Tuzcu; Eric D Peterson; Susan Fitzgerald; Matina Kourtis; Joan Michaels; Barbara Christensen; William F Seward; Kathleen Hewitt; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2016-12-09       Impact factor: 24.094

9.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Martin B Leon; Craig R Smith; Michael J Mack; Raj R Makkar; Lars G Svensson; Susheel K Kodali; Vinod H Thourani; E Murat Tuzcu; D Craig Miller; Howard C Herrmann; Darshan Doshi; David J Cohen; Augusto D Pichard; Samir Kapadia; Todd Dewey; Vasilis Babaliaros; Wilson Y Szeto; Mathew R Williams; Dean Kereiakes; Alan Zajarias; Kevin L Greason; Brian K Whisenant; Robert W Hodson; Jeffrey W Moses; Alfredo Trento; David L Brown; William F Fearon; Philippe Pibarot; Rebecca T Hahn; Wael A Jaber; William N Anderson; Maria C Alu; John G Webb
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

10.  Association of Clinical and Economic Outcomes With Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement.

Authors:  Talal Aljabbary; Feng Qiu; Shannon Masih; Jiming Fang; Gabby Elbaz-Greener; Peter C Austin; Josep Rodés-Cabau; Dennis T Ko; Sheldon Singh; Harindra C Wijeysundera
Journal:  JAMA Netw Open       Date:  2018-05-18
View more
  1 in total

Review 1.  Application of cardiovascular 3-dimensional printing in Transcatheter aortic valve replacement.

Authors:  Yanyan Ma; Yu Mao; Guangyu Zhu; Jian Yang
Journal:  Cell Regen       Date:  2022-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.